Atovaquone and Proguanil HCl is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Atovaquone; Proguanil Hydrochloride.
Product ID | 43063-522_7fc278b2-1478-6b90-e053-2a91aa0a55b3 |
NDC | 43063-522 |
Product Type | Human Prescription Drug |
Proprietary Name | Atovaquone and Proguanil HCl |
Generic Name | Atovaquone And Proguanil Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2012-07-27 |
Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
Application Number | NDA021078 |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
Active Ingredient Strength | 250 mg/1; mg/1 |
Pharm Classes | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-01-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA authorized generic |
Application Number | NDA021078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-30 |
Marketing Category | NDA authorized generic |
Application Number | NDA021078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-30 |
Marketing Category | NDA authorized generic |
Application Number | NDA021078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-30 |
Marketing Category | NDA authorized generic |
Application Number | NDA021078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-30 |
Marketing Category | NDA authorized generic |
Application Number | NDA021078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-30 |
Marketing Category | NDA authorized generic |
Application Number | NDA021078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-30 |
Marketing Category | NDA authorized generic |
Application Number | NDA021078 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-30 |
Ingredient | Strength |
---|---|
ATOVAQUONE | 250 mg/1 |
SPL SET ID: | dcf43cbd-fc97-4dc1-a258-afad6cf4cabf |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
43063-522 | Atovaquone and Proguanil HCl | atovaquone and proguanil hydrochloride |
50090-2980 | Atovaquone and Proguanil HCl | atovaquone and proguanil hydrochloride |
63629-5531 | Atovaquone and Proguanil HCl | Atovaquone and Proguanil HCl |
66993-060 | Atovaquone and Proguanil HCl | Atovaquone and Proguanil HCl |
0378-4160 | Atovaquone and Proguanil Hydrochloride | atovaquone and proguanil hydrochloride |
0378-4162 | Atovaquone and Proguanil Hydrochloride | atovaquone and proguanil hydrochloride |
10544-909 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
33261-900 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
42254-150 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
43063-393 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
50090-1302 | Atovaquone and Proguanil Hydrochloride | Atovaquone and Proguanil Hydrochloride |
0173-0675 | MALARONE | atovaquone and proguanil hydrochloride |
0173-0676 | MALARONE | atovaquone and proguanil hydrochloride |
50090-0687 | MALARONE | atovaquone and proguanil hydrochloride |
50090-0688 | MALARONE | atovaquone and proguanil hydrochloride |